Agra Ventures - Incoming CEO, David Grand.
Incoming CEO, David Grand.
Source: Muskoka Grown.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Agra Ventures (AGRA) has appointed David Grand as its new CEO
  • He most recently served as founder and CEO of Muskoka Grown Limited from 2013 to 2020
  • The transition will become effective on July 1, 2022, with outgoing CEO, Elise Coppens, remaining with the company as a director
  • Agra Ventures is dedicated to the cultivation, distribution and marketing of cannabis products worldwide
  • Agra Ventures (AGRA) closed down by 7.14 per cent trading at $0.065 per share

Agra Ventures (AGRA) has appointed David Grand as its new CEO.

Grand has over 30 years of experience from leading high-growth startups to national companies. His previous roles include:

  • Founder and CEO of Muskoka Grown Limited from 2013 to 2020
  • CFO for GenCanna from 2014 to 2015
  • President and Managing Director of the Private Client Division at Hampton Securities Limited from 2012-2014
  • Head of Retail Sales at Octagon Capital Corporation from 2004 to 2010

The transition will become effective as of July 1, 2022. Outgoing CEO, Elise Coppens, will remain as a member of Agra’s Board of Directors.

“Streamlining the company over the last year-and-a-half was necessary to position it for this transition and set AGRA’s next leader up for success,” stated Coppens. “I look forward to David putting his stamp on the company and working hard to navigate the competitive landscape and create value.”

Agra Ventures is a diversified growth-oriented company dedicated to the cultivation, distribution and marketing of cannabis products worldwide.

Agra Ventures (AGRA) closed down by 7.14 per cent trading at $0.065 per share.

More From The Market Herald

" Aleafia Health (TSX:AH) earns record quarter-over-quarter revenue in Q1 2023

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.
InnoCan - Founder and CEO, Iris Bincovich.

" Innocan Pharma (CSE:INNO) approaches 100 per cent CBD bioavailability for its LPT CBD liposomal delivery platform

Innocan Pharma (INNO) has announced results from a clinical study on dogs suffering from pain.

" Bhang (CSE:BHNG) President/CEO and Director stepping down

Bhang’s (BHNG) President/CEO and Director Jamie Pearson is stepping down after seven years with the company.

" The Flowr Corporation (TSXV:FLWR) welcomes new CEO, Chairman, Director

The Flowr Corporation (FLWR) has announced several leadership and governance changes.